Clinical Trial Update: Utilization of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Healing [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial studying the safety and effectiveness of amniotic membrane extract eye drops (AMEED) for healing corneal injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Injury

Drugs mentioned

• Amniotic Membrane Extract Eye Drop (AMEED) (amniotic membrane extract eye drop)

Snippet

Sponsor: Royan Institute | Conditions: Cornea Injury | Phase 1, Phase 2 | Status: COMPLETED